dc.creatorSabaj, Valeria
dc.creatorGalindo, Mario A.
dc.creatorSilva, Daniela
dc.creatorSandoval, Lea
dc.creatorRodríguez, Juan C.
dc.date.accessioned2019-03-11T13:00:11Z
dc.date.available2019-03-11T13:00:11Z
dc.date.created2019-03-11T13:00:11Z
dc.date.issued2010
dc.identifierMolecular Biology Reports, Volumen 37, Issue 6, 2018, Pages 2927-2933
dc.identifier03014851
dc.identifier15734978
dc.identifier10.1007/s11033-009-9854-2
dc.identifierhttps://repositorio.uchile.cl/handle/2250/165051
dc.description.abstractToxoplasma gondii is one of the most successful protozoan parasites given its ability to manipulate the immune system and establish a chronic infection. It is a parasite with a significant impact on human health, mainly in immunocompromised patients. In Europe and North America, only a few clonal genotypes (I, II and III) seem to be responsible for the vast majority of Toxoplasma infections. Surface antigen 2 gene (SAG2) has been extensively used for genotyping T. gondii isolates. The analysis of this locus reveals that in Northern hemisphere, human disease causing isolates are mainly type II, whereas T. gondii isolated from different animals are both type II and III. Since the immune response depends on parasite genotype, it seems relevant to characterize parasites producing human toxoplasmosis in different geographical areas. The growing information about the prevalent T. gondii genotypes in South America mostly refers to domestic animals. This is the first report of genetic characte
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceMolecular Biology Reports
dc.subjectGenotyping
dc.subjectSAG2
dc.subjectToxoplasma gondii
dc.subjectToxoplasmosis
dc.titleAnalysis of Toxoplasma gondii surface antigen 2 gene (SAG2). Relevance of genotype i in clinical toxoplasmosis
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución